Targeted biomarketing

Helping Biotech Businesses Grow

Communicating presents an image of openness, engendering trust; when you don't communicate, people soon think the worst. Biopharmaceutical companies frequently ignore corporate marketing until too late in the game: Public relations should start at inception to help companies start out correctly.

In November 1998, FDA approved Enbrel (etanercept, a monotherapy tumor necrosis factor inhibitor) for treatment of rheumatoid arthritis, a debilitating disease that until then had no effective remedy. In January 2002, the drug was also approved for psoriatic arthritis. Produced by Seattle-based Immunex Corporation, the biopharmaceutical is hailed as …